103 related articles for article (PubMed ID: 21812333)
1. Pharmacokinetics of hydroxycamptothecin nanosuspensions in rats.
Wang L; Hua HY; Liu WJ; Zhao YX; Zhang ZZ
Pharmazie; 2011 Jul; 66(7):547-8. PubMed ID: 21812333
[TBL] [Abstract][Full Text] [Related]
2. 10-Hydroxycamptothecin (HCPT) nanosuspensions stabilized by mPEG
Yang L; Hong J; Di J; Guo Y; Han M; Liu M; Wang X
Int J Nanomedicine; 2017; 12():3681-3695. PubMed ID: 28553107
[TBL] [Abstract][Full Text] [Related]
3. Preparation, characterization, biodistribution and antitumor efficacy of hydroxycamptothecin nanosuspensions.
Han M; Liu X; Guo Y; Wang Y; Wang X
Int J Pharm; 2013 Oct; 455(1-2):85-92. PubMed ID: 23928147
[TBL] [Abstract][Full Text] [Related]
4. Lipid nanoparticles loaded with 7-ethyl-10-hydroxycamptothecin-phospholipid complex: in vitro and in vivo studies.
Liu H; Lu H; Liao L; Zhang X; Gong T; Zhang Z
Drug Deliv; 2015; 22(6):701-9. PubMed ID: 24625262
[TBL] [Abstract][Full Text] [Related]
5. High Drug Payload 10-Hydroxycamptothecin Nanosuspensions Stabilized by Cholesterol-PEG: In Vitro and In Vivo Investigation.
Yang L; Jiang J; Hong J; Di J; Liao Y; Kuang H; Wang X
J Biomed Nanotechnol; 2015 Apr; 11(4):711-21. PubMed ID: 26310077
[TBL] [Abstract][Full Text] [Related]
6. Effect of injection routes on pharmacokinetics and lactone/carboxylate equilibrium of 9-Nitrocamptothecin in rats.
Chen J; Ping Q; Guo J; Liu M; Cai B
Int J Pharm; 2007 Aug; 340(1-2):29-33. PubMed ID: 17446016
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of SN2310, an injectable emulsion that incorporates a new derivative of SN-38 in patients with advanced solid tumors.
Marier JF; Pheng L; Trinh MM; Burris HA; Jones S; Anderson K; Warner S; Porubek D
J Pharm Sci; 2011 Oct; 100(10):4536-45. PubMed ID: 21630281
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacokinetics and tissue distribution of irinotecan hydrochloride nanoparticles].
Yang FY; Zhang WP; Chen HL; Fu Y; Wang XY; Wei SJ; Yang XY; Zhang YX; Dang HW
Yao Xue Xue Bao; 2013 Jun; 48(6):940-5. PubMed ID: 23984532
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacokinetics of SN-38 in rats and tissue distribution of 7-ethyl-10-hydroxycamptothecin in mice after intravenous injection of irinotecan hydrochloride nanoparticles].
Yang FY; Zhang WP; Wang XY; Yang WC; Dang HW
Yao Xue Xue Bao; 2014 Jul; 49(7):1029-33. PubMed ID: 25233635
[TBL] [Abstract][Full Text] [Related]
10. [Distribution of hydroxycamptothecin after aerosol inhalation in rabbits].
Chen J; Fang Y; Zhang HX; Huang LL; Qian XP; Liu BR
Yao Xue Xue Bao; 2004 Sep; 39(9):747-51. PubMed ID: 15606028
[TBL] [Abstract][Full Text] [Related]
11. Preparation and cytotoxic activity of hydroxycamptothecin nanosuspensions.
Zhao YX; Hua HY; Chang M; Liu WJ; Zhao Y; Liu HM
Int J Pharm; 2010 Jun; 392(1-2):64-71. PubMed ID: 20302926
[TBL] [Abstract][Full Text] [Related]
12. Preparation, characterization and biodistribution of the lactone form of 10-hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticles.
Yang L; Cui F; Cun D; Tao A; Shi K; Lin W
Int J Pharm; 2007 Aug; 340(1-2):163-72. PubMed ID: 17482779
[TBL] [Abstract][Full Text] [Related]
13. Modified hydrolysis kinetics of the active lactone moiety of 10-hydroxycamptothecin by liposomal encapsulation.
Shi K; Tian Y; Jiang Y; Wang L; Cui F
Pharm Dev Technol; 2010 Dec; 15(6):644-52. PubMed ID: 19943738
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of DE-310, a novel macromolecular carrier system for the camptothecin analog DX-8951f, in tumor-bearing mice.
Masubuchi N
Pharmazie; 2004 May; 59(5):374-7. PubMed ID: 15212304
[TBL] [Abstract][Full Text] [Related]
15. In-vivo pharmacokinetics, tissue distribution and anti-tumour effect of hydroxycamptothecin delivered in oil-in-water submicron emulsions.
Zhao YX; Liu DX; Liang WQ; Ye ZW
J Pharm Pharmacol; 2012 Jun; 64(6):783-91. PubMed ID: 22571256
[TBL] [Abstract][Full Text] [Related]
16. Studies on pharmacokinetics and tissue distribution of oridonin nanosuspensions.
Gao L; Zhang D; Chen M; Duan C; Dai W; Jia L; Zhao W
Int J Pharm; 2008 May; 355(1-2):321-7. PubMed ID: 18242896
[TBL] [Abstract][Full Text] [Related]
17. [Pharmaceutical evaluation of hydroxycamptothecin nanosuspensions with the action of inhibiting P-gp].
Pu XH; Sun J; Qin YM; Zhang X; Zhang P; He ZG
Yao Xue Xue Bao; 2011 Jul; 46(7):834-8. PubMed ID: 22010354
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacokinetic study of intraperitoneal chemotherapy with HCPT].
Ye M; Lin XX; Pan HM; Li N; Lou F; Jin W; Zheng Y; Wu JM
Zhongguo Zhong Yao Za Zhi; 2005 Oct; 30(20):1610-2. PubMed ID: 16422545
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and tissue distribution study of 10-methoxycamptothecin in rats following intragastric administration.
Zheng J; Ji Y; Shao C; Jing L; Wang Y
J Pharm Biomed Anal; 2018 Feb; 149():564-571. PubMed ID: 29197298
[TBL] [Abstract][Full Text] [Related]
20. Effect of P-glycoprotein inhibitor, verapamil, on oral bioavailability and pharmacokinetics of irinotecan in rats.
Bansal T; Mishra G; Jaggi M; Khar RK; Talegaonkar S
Eur J Pharm Sci; 2009 Mar; 36(4-5):580-90. PubMed ID: 19135530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
